SUD 0.00% 4.2¢ suda pharmaceuticals ltd

I get the impression and speculate in the absence of a large...

  1. 1,410 Posts.
    lightbulb Created with Sketch. 131
    I get the impression and speculate in the absence of a large commercial deal that the collective activity recently and over past 12 months associated with SUDA reeks of a well planned and soon to be executed (6-12 months) LBO. (LBO means low ball takeover offer by another company)

    Imo reasons why:
    1. Recent deals by SUDA with international and Aus. companies i.e. Strides, AYTU, ZLD has resulted in significant share price appreciation for those companies but not SUDA.

    2. SUDA did not prepare a dual press release with the recent SUDA/AYTU news, that sent AYTU share price rocketing. The market to a small degree were aware of AYTU release and this was reflected with all SUDA .005 being purchased the morning of AYTU release with support building at .005 and sellers at .006. No release by SUDA was made and the sp quickly returned to all time low levels. AYTU retained its impressive gains from the release.

    3. Every time SUDA share price moves an increment in positive territory it is almost instantly countered by a center point cross trade to drop it back. (this is happening everyday (over the last 12 weeks at the moment and mainly most importantly when the sp is stagnant)

    4. Sell side at .005 continues to increase.

    5. Over 70% of the share register free float (i.e. not held by the top 20) is available to the market.

    6. Constant relentless negativity by so called long term holders, if you guys are genuine would you consider that you are assisting an LBO come to fruition in the greatest possible way with your collective efforts. Either that or one could speculate you are in on it.

    7. Normally current management would secure their future positions in the event of an LBO succeeding and would not be affected by loss of employment.

    8. Talk floating around of company sitting on and not releasing news that perhaps would have a positive impact on current share price.

    9. Accounting errors in financial reports or upcoming payments not shown where they should be.

    10. Large local and international companies are very interested in SUDA we all know this.

    11. Current updates do not create any certainty or prove forward progress for the market to reasonably speculate on that would deliver a measure of future success.

    12. Nearly 4 months into a new year, lots of positive developments and blue sky potential but share price remains suppressed at all time lows.

    13. SUDA has products ready to go in key areas of significant pharma interest.

    Only one thing can squash all the LBO speculation above and that is a major deal that brings significant funds into the companies bank account and would also see significant gains in the share price that held firm. I remain positive of the later.
 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.